Novelix Pharmaceuticals Limited (BOM:536565)

India flag India · Delayed Price · Currency is INR
55.53
-0.56 (-1.00%)
At close: Apr 28, 2026
108.68%
Market Cap 1.11B
Revenue (ttm) 1.28B
Net Income (ttm) 18.06M
Shares Out 19.94M
EPS (ttm) 1.20
PE Ratio 46.34
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 930
Average Volume 8,175
Open 56.50
Previous Close 56.09
Day's Range 55.30 - 57.55
52-Week Range 26.61 - 70.16
Beta 0.50
RSI 50.47
Earnings Date May 26, 2026

About Novelix Pharmaceuticals

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India. [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1994
Employees 8
Stock Exchange Bombay Stock Exchange
Ticker Symbol 536565
Full Company Profile

Financial Performance

In fiscal year 2025, Novelix Pharmaceuticals's revenue was 307.33 million, an increase of 578.26% compared to the previous year's 45.31 million. Earnings were 845,200, an increase of 711.76%.

Financial Statements

News

There is no news available yet.